News & Events

News

Trends in Utilization Management for Oncology Therapies Amongst US Commercial Health Plans: 2017-2024

US commercial payers are increasingly applying utilization management (UM) for oncology therapies, with important implications for costs, clinical pra...

Read more May 22, 2026

Peter Neumann Discusses Drug Pricing Policy on Leerink Center for Pharmacoeconomic Podcast

Peter Neumann joined Melanie Whittington, Managing Director and Head of the Leerink Center for Pharmacoeconomics and CEVR Senior Fellow, to discuss co...

Read more May 12, 2026

CEVR Spring 2026 Newsletter

Read CEVR's Spring 2026 Newsletter....

Read more May 7, 2026

View All News Items

Events

CEVR Health Policy Seminar with Melanie Calvert, PhD, FMedSci

2026 CEVR Annual Meeting

CEVR Participation at ISPOR EU 2025

November 10–12, 2025

View All Events

Publications

Health Affairs Forefront

Lessons From TAVR For Medicare’s ‘Coverage With Evidence Development’ Program

Learning Health Systems

Effect of Using Personalized Estimates of Diabetes Risk During Primary Care Visits for People With Prediabetes

JCO Oncology Practice

Trends in Utilization Management for Oncology Therapies Amongst US Commercial Health Plans: 2017-2024

ISPOR 2026 (Poster Presentation)

Variation in Commercial Health Plan Coverage of Atopic Dermatitis Therapies

ISPOR 2026 (Poster Presentation)

Alignment of Health Plan Reauthorization Criteria with Clinical Trial Endpoints for Neuromuscular Disease Therapies

ISPOR 2026 (Poster Presentation)

FDA Approvals of Specialty Drugs, 2000-2024

ISPOR 2026 (Poster Presentation)

A Survey of HEOR Leaders in Pharma on the Changing US Policy Landscape

ISPOR 2026 (Poster Presentation)

The Unintended Consequences of the Inflation Reduction Act on Biosimilar Market Incentives and Medicare Savings

ISPOR 2026 (Poster Presentation)

Trends in Specialty Drug Coverage Policy Complexity Among US Commercial Health Plans

View All Publications